omation mbers - Society for Laboratory Automation and Screening

omation mbers - Society for Laboratory Automation and Screening omation mbers - Society for Laboratory Automation and Screening

13.01.2013 Views

12:00 pm Wednesday, February 4 High Throughput Screening – Analytical Room A2 Rebecca Zangmeister National Institute of Standards and Technology 100 Bureau Drive, MS 8362 Gaithersburg, Maryland 20899 razang@nist.gov Integration of Hydrogel Based Bioassays Into Microfluidic Channels 64 Co-Author(s) Michael J. Tarlov We previously reported a method for immobilizing single-stranded DNA (ss-DNA) probe molecules in polyacrylamide hydrogels within plastic microfluidic channels. Low concentrations of fluorescent-tagged ss-DNA targets hybridize with immobilized probes and are detected in the hydrogels. We aim to couple two novel bioassays with this basic technology. The first is a diagnostic DNA assay that does not require pre-labeling of the target strand prior to analysis. The assay is based on the displacement of a short sacrificial fluorescent-tagged indicator oligomer by a longer untagged target sequence as it is electrophoresed through a DNA-containing hydrogel plug immobilized in a microfluidic channel. The distinct advantage of this assay is the ability to detect non-labeled target DNA. The second is a lead sensitive assay, based on the response of catalytic DNA to Pb(II) ions. Our goal is to immobilize the enzyme strand sequence of the catalytic DNA duplex in a hydrogel plug immobilized in a microfluidic channel. Fluorescently tagged substrate strands are electrophoresed into the hydrogel plug where they hybridize with the immobilized enzyme strands, forming the catalytic DNA system. Electrophoretic migration of Pb(II) ions through the hydrogel plug results in catalytic cleavage of the substrate strand and release of the fluorescent-tagged sequence fragment that is detected in a second capture plug. Both assays feature enhanced sensitivity due to high loading of DNA probes in the hydrogel plugs, the spatially confined, directed mass transfer characteristics of the microfluidic channels, and the inherently low fluorescent background of the hydrogels. 3:30 pm Wednesday, February 4 High Throughput Screening – Data Analysis and QC Room A2 Anthony Carlo Pfizer Eastern Point Road Groton, Connecticut 06340 Anthony_A_Carlo@groton.pfizer.com Evotec µHTS Data Analysis – Making the Most of the Multiparametric Readout This presentation will discuss our efforts towards improving hit detection in lead discovery by increasing the confidence of identifying true positives verses false positives/negatives in primary HTS data. Towards this goal, the talk will focus on the use of single molecule fluorescence detection provided by the Evotec OAI µHTS platform, which provides multi-parametric data readout from miniaturized assay formats and how this information is processed. These techniques will be applied across multiple HTS assays.

4:00 pm Wednesday, February 4 High Throughput Screening – Data Analysis and QC Room A2 Hanspeter Gubler Novartis Institutes for BioMedical Research WSJ-350.E15 Basel, CH-4002 Switzerland hanspeter.gubler@pharma.novartis.com 65 Co-Author(s) Michel Girod, Sigmar Dressler, Rochdi Bouhelal, Daniela Gabriel, Johannes Ottl, Kamal Azzaoui HTS Data Analysis in the Real World: Practical Experience With HTS Data Quality Assurance Systems and Recent Integration of the GeneData Screener Software The application of comprehensive quality control and sophisticated data correction algorithms to High Throughput Screening (HTS) data has a long standing history in the NIBR Lead Discovery Center (LDC). Fully automated inhouse systems are sifting through HTS raw data to check quality and to detect and correct many systematic errors. Some lacking aspects – most importantly interactive data visualization, comprehensive statistical analyses and possibilities for easy cross-assay investigations – have led NIBR to enter into a system development collaboration with GeneData in 2002. The GeneData “Screener” software is tightly integrated to the LDC HTS data processing systems. Standardized instrument raw data with necessary experimental context information are automatically entering the “Screener” system in a near “real time” fashion. Data are thus readily available to the scientists for analysis and – if necessary – correction of systematic patterns. Additional software modules are used for hit selection, including results from other assays, either historical or direct counter screens. The combination of advanced assay technology with the application of sophisticated quality control, error detection and data correction algorithms (quality assurance) lead to improvements in HTS efficiency. We demonstrate this with a few case studies from our HTS labs. In addition, we provide some further insight into the performance of the pattern correction algorithms by applying them to simulated data of known intrinsic activity – and error structure. 4:30 pm Wednesday, February 4 High Throughput Screening – Data Analysis and QC Room A2 Maneessha Altekar GlaxoSmithKline 709 Swedeland Road, Mail Stop UW2110 King of Prussia, Pennsylvania 19406-0939 maneesha.2.altekar@gsk.com On-Line QC for High Throughput Screening Co-Author(s) Glenn Hofmann, Isabel Coma, Jesus Herranz, Liz Clark, Gavin Harper, Mark Lennon, Frances Stewart GlaxoSmithKline’s migration from the HTS laboratory to the HTS automation factory is expected to result in greater throughput for screening. Thus there is a need to put data analysis systems in place to monitor the quality of the screens in real time to ensure that any wastage of compounds, reagents and other materials is held to a minimum if things go wrong during a run. The on-line QC process has been developed to perform plate level calculations and determine the health of a plate or the screening run at any given time according to specified business rules. Initially, plate failures or run stoppages due to business rules will be rare as screeners gain experience with using the system and evaluate the sensitivity of the business rules being applied. The initial purpose of the system is diagnosis rather than remedy, with the screeners being informed of problems as they occur. The ultimate goal is to automate the system to provide feedback in to the screening process that will result in the robotic platform pausing or stopping the run as appropriate. PODIUM ABSTRACTS

12:00 pm Wednesday, February 4 High Throughput <strong>Screening</strong> – Analytical Room A2<br />

Rebecca Zangmeister<br />

National Institute of St<strong>and</strong>ards <strong>and</strong> Technology<br />

100 Bureau Drive, MS 8362<br />

Gaithersburg, Maryl<strong>and</strong> 20899<br />

razang@nist.gov<br />

Integration of Hydrogel Based Bioassays Into Microfluidic Channels<br />

64<br />

Co-Author(s)<br />

Michael J. Tarlov<br />

We previously reported a method <strong>for</strong> immobilizing single-str<strong>and</strong>ed DNA (ss-DNA) probe molecules in<br />

polyacrylamide hydrogels within plastic microfluidic channels. Low concentrations of fluorescent-tagged ss-DNA<br />

targets hybridize with immobilized probes <strong>and</strong> are detected in the hydrogels. We aim to couple two novel bioassays<br />

with this basic technology. The first is a diagnostic DNA assay that does not require pre-labeling of the target str<strong>and</strong><br />

prior to analysis. The assay is based on the displacement of a short sacrificial fluorescent-tagged indicator oligomer<br />

by a longer untagged target sequence as it is electrophoresed through a DNA-containing hydrogel plug immobilized<br />

in a microfluidic channel. The distinct advantage of this assay is the ability to detect non-labeled target DNA. The<br />

second is a lead sensitive assay, based on the response of catalytic DNA to Pb(II) ions. Our goal is to immobilize<br />

the enzyme str<strong>and</strong> sequence of the catalytic DNA duplex in a hydrogel plug immobilized in a microfluidic channel.<br />

Fluorescently tagged substrate str<strong>and</strong>s are electrophoresed into the hydrogel plug where they hybridize with the<br />

immobilized enzyme str<strong>and</strong>s, <strong>for</strong>ming the catalytic DNA system. Electrophoretic migration of Pb(II) ions through the<br />

hydrogel plug results in catalytic cleavage of the substrate str<strong>and</strong> <strong>and</strong> release of the fluorescent-tagged sequence<br />

fragment that is detected in a second capture plug. Both assays feature enhanced sensitivity due to high loading of<br />

DNA probes in the hydrogel plugs, the spatially confined, directed mass transfer characteristics of the microfluidic<br />

channels, <strong>and</strong> the inherently low fluorescent background of the hydrogels.<br />

3:30 pm Wednesday, February 4 High Throughput <strong>Screening</strong> – Data Analysis <strong>and</strong> QC Room A2<br />

Anthony Carlo<br />

Pfizer<br />

Eastern Point Road<br />

Groton, Connecticut 06340<br />

Anthony_A_Carlo@groton.pfizer.com<br />

Evotec µHTS Data Analysis – Making the Most of the Multiparametric Readout<br />

This presentation will discuss our ef<strong>for</strong>ts towards improving hit detection in lead discovery by increasing the<br />

confidence of identifying true positives verses false positives/negatives in primary HTS data. Towards this goal, the<br />

talk will focus on the use of single molecule fluorescence detection provided by the Evotec OAI µHTS plat<strong>for</strong>m,<br />

which provides multi-parametric data readout from miniaturized assay <strong>for</strong>mats <strong>and</strong> how this in<strong>for</strong>mation is<br />

processed. These techniques will be applied across multiple HTS assays.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!